You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 12, November 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (63)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Spectrum of Pheochromocytoma in Hypertensive Patients With Neurofibromatosis

Victor Kalff, MB, BS; Brahm Shapiro, MB, ChB, PhD; Ricardo Lloyd, MD; James C. Sisson, MD; Kurt Holland, MD; Masayuki Nakajo, MD; William H. Beierwaltes, MD

Arch Intern Med. 1982;142(12):2092-2098.


Abstract



• We have found an appreciable number of pheochromocytomas in patients with neurofibromatosis and concurrent hypertension (ten of 18 cases). At diagnosis, the patient age range was 15 to 62 years, the clinical appearance of the neurofibromatosis did not predict who would and who would not have pheochromocytomas, but the age at diagnosis was helpful in that our younger patients tended to have causes of hypertension other than pheochromocytoma. However, several causes of hypertension may coexist. The biochemical findings were highly diagnostic. The pheochromocytomas secreted epinephrine as well as norepinephrine and resided in or next to the adrenal gland. Where pheochromocytoma is the cause of hypertension, its resection generally results in a better control of hypertension than that obtained in patients whose BPs were elevated from other unknown causes.

(Arch Intern Med 1982;142:2092-2098)



Author Affiliations



From the Divisions of Nuclear Medicine (Drs Kalff, Shapiro, Sisson, Holland, Nakajo, and Beierwaltes) and Pathology (Dr Lloyd), University of Michigan, Ann Arbor.


Footnotes



Accepted for publication June 18, 1982.

Reprint requests to Division of Nuclear Medicine, University of Michigan Medical Center, 1405 E Ann St, Ann Arbor, MI 48109 (Dr Sisson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurofibromatosis: clinical presentations and anaesthetic implications
Hirsch et al.
Br J Anaesth 2001;86:555-564.
ABSTRACT | FULL TEXT  

Iodine 131--Labeled Metaiodobenzylguanidine Scintigraphy and Biochemical Analyses in Suspected Pheochromocytoma
Hanson et al.
Arch Intern Med 1991;151:1397-1402.
ABSTRACT  

Clinically Unsuspected Pheochromocytomas: Experience at Henry Ford Hospital and a Review of the Literature
Krane
Arch Intern Med 1986;146:54-57.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.